Abbott Said to Agree to Buy Alere For $51/Shr; Ends Lawsuit: FT
Alert: HALISTER
Source: BFW (Bloomberg First Word)
Tickers
ALR US (Alere Inc)
ABT US (Abbott Laboratories)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283
(Bloomberg) -- Abbott ends legal battle by agreeing to buy Alere at $51/share rather than $56/share, FT reports, citing unidentified people close to the matter.
- Expected to be announced imminently; values Alere’s equity at $4.4b
Alert: HALISTER
Source: BFW (Bloomberg First Word)
Tickers
ALR US (Alere Inc)
ABT US (Abbott Laboratories)
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283